A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma
NCT01547546
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
29
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioblastoma, Glioma
Interventions
DRUG:
GDC-0084
Sponsor
Genentech, Inc.